Science

Injectable nanoparticles make blind retinas respond to light in preclinical study

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 22/09/2026, 22:55:24 UTC.

Briefings

An international research team developed microscopic particles acting as light receptors that, when injected into the eye, settle near retinal nerve cells. Upon light exposure, these particles trigger electrical and chemical processes activating the nerve cells to send signals to the brain. This breakthrough offers a potential pathway for restoring vision in blind individuals through targeted light stimulation.

Key points

• Microscopic particles act as light receptors that settle near retinal nerve cells after injection.
• Particles trigger electrical and chemical processes when exposed to light, activating nerve cells to send signals to the brain.

Context and limitations

This study is preclinical and conducted on animal models; human clinical trials are not yet reported.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 22/09/2026, 23:02:45 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeihtc2lzcdesg2plobxvp3keidsn3kwjuuu3qrsposywwlqfctck3m